Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
-
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
-
Australian Oilseeds Announces Second Quarter Fiscal 2025 Financial Results
-
Luckin Coffee Files 2024 Annual Report on Form 20-F
-
Biora Therapeutics Successfully Completes Restructuring Process
-
360 Privacy Announces Strategic Executive Appointments Following $36 Million Growth Investment
-
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
-
Nasdaq Champions Smart Regulatory Reform to Strengthen the World’s Leading Capital Markets and Drive American Economic Growth
-
Clip Money Inc. Reports 2024 Year End Results
-
Emergent BioSolutions Announces Stock Repurchase Program
-
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
Community “Angels" Help Kids, Families, Seniors, Veterans and the Unhoused to Receive Free Vision Care and More
-
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
-
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
-
Trump Media to Debut on New York Stock Exchange Texas
-
BetterLife Pharma Appoints New Director
-
GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
-
Veritex Holdings, Inc. Announces Extension of Stock Buyback Program
-
Tax Season Scams: Regula Unveils the Tax Fraud Awareness Guide to Help Americans Safeguard Their Identity
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
-
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
JDE Peet’s share buyback periodic update March 31, 2025
-
Awilco Drilling PLC: Notice of Extraordinary General Meeting
-
ASML reports transactions under its current share buyback program
-
Regenx Announces Non-Brokered Financing for Gross Proceeds of $679,032
-
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
-
BIO-key Partners with Arrow ECS Iberia to Strengthen Access to its Identity and Access Management Solutions in Spain and Portugal
-
Transactions in connection with share buyback programme
-
Intetics Ranks Among America’s Most Innovative Companies for 2025 – A True Tech Leader
-
Steakholder Foods Reports 2024 Financial Results and Provides Business Update
-
Edible Garden Reports 181.3% Year-over-Year Gross Profit Increase for 2024
-
Form 8.3 - Octopus Investments - Advanced Medical Solutions Group plc
-
SAB BIO Reports Full Year 2024 Operating and Financial Results
-
Westhaven Announces Leadership Changes; Appoints Armstrong President & CEO
-
Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project
-
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
-
Diginex Limited and Forvis Mazars Announce Strategic Alliance to Enhance Supply Chain Risk Assessment with diginexLUMEN
-
BOS Reports Financial Results for the Fourth Quarter and Full Year 2024
-
FTI Consulting Announces Election of Eric Steigerwalt and Janet Zelenka as Independent Directors
-
Digi Power X Reports Record 2024 Financial Results With 42% Revenue Growth and 228% EBITDA Turnaround
-
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
-
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Dovre Group: CFO resigns
-
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
-
L3Harris’ Commercial Aviation Solutions (CAS) Business, now known as Acron Aviation
-
Ingersoll Rand Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
-
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
-
Net Asset Value(s)

